GlassScriptPhysician profile
Michael P Lynch
NPI 1699909853
$1,915.90
in general payments reported to CMS, 2019-2025
12 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $605 · 2021: $144 · 2022: $454 · 2023: $67.97 · 2024: $111 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $783.19 | 2020-2022 | |
| Allergan, INC. | $572.30 | 2019-2022 | |
| Rti Surgical, INC | $110.32 | 2024-2025 | |
| Integra Lifesciences Corporation | $103.19 | 2023-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Motiva USA, LLC | $74.37 | 2024-2025 | |
| Coopersurgical, INC. | $65.75 | 2020-2021 | |
| Abbvie INC. | $54.97 | 2023-2025 | |
| Ethicon US, LLC | $49.78 | 2019-2025 | Stratafix |
| Davol INC. | $38.34 | 2025 | Phasix Mesh |
| Merz North America, INC. | $33.94 | 2019 | |
| Stryker Corporation | $15.88 | 2025 | Spy-Phi System |
| Galderma Laboratories, L.P. | $13.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.